Stock data
Myriad Genetics, Inc. (MYGN)
Myriad Genetics, Inc. (MYGN) reported revenue of US$824.50M and net income of -US$365.90M for fiscal 2025. The figures below come from the company's SEC filings.
Annual results
Data as of 2025-12-31
| Fiscal year | Revenue | Gross profit | Operating income | Net income | Diluted EPS |
|---|---|---|---|---|---|
| 2025 | US$824.50M | US$576.60M | -US$387.20M | -US$365.90M | — |
| 2024 | US$837.60M | US$585.40M | -US$123.50M | -US$127.30M | — |
| 2023 | US$753.20M | US$517.00M | -US$257.40M | -US$263.30M | — |
| 2022 | US$678.40M | US$476.40M | -US$140.60M | -US$112.00M | — |
| 2021 | US$690.60M | — | -US$190.50M | -US$27.20M | — |
Quarterly results
Data as of 2026-06-30
| Quarter | Revenue | Net income | Diluted EPS |
|---|---|---|---|
| 2026-06-30 | US$190.70M | -US$43.20M | — |
| 2026-03-31 | US$200.40M | -US$34.10M | — |
| 2025-12-31 | US$209.80M | -US$7.90M | — |
| 2025-09-30 | US$205.70M | -US$27.40M | — |
| 2025-06-30 | US$213.10M | -US$330.50M | — |
| 2025-03-31 | US$195.90M | -US$0.10M | — |
| 2024-12-31 | US$210.60M | -US$42.50M | — |
| 2024-09-30 | US$213.30M | -US$22.10M | — |
Sources
- Source: SEC EDGAR company facts
Charts, drawing tools, and the P/E calculator are in the app, free to use.